Integrated Safety Analysis of Abrocitinib in 635 Adolescent Patients With Moderate-To-Severe Atopic Dermatitis With Over 1000 Patient-Years of Exposure. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 2, p. s379, 2024. DOI: 10.25251/skin.8.supp.379. Disponível em: https://skin.dermsquared.com/skin/article/view/2690. Acesso em: 18 apr. 2025.